Dusquetide Completed Phase 2 Trials for Oral Mucositis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02013050A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer